🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

xinan Lu

China National Pharmaceutical Group Corporation (China)

ORCID: 0000-0003-4721-1684
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A
0Author DataRank · unranked

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 1 paper. Top paper: Distribution Measurements of Chimeric Antigen Receptor-Modified T Cells Against CD19.

0 citations

Ting He, Xiaopei Wang, Wen Zheng, Ningjing Lin, Meifeng Tu +16 more